Loading...
Loading...
Application UK00918095804 · Registered
| Application Number | UK00918095804 |
| Status | Registered |
| Owner | Samsung Bioepis Co., Ltd. |
| Filed | 2019-07-16 |
| Registered | 2019-10-26 |
| Renewal Due | 2029-07-16 |
| Type | Individual |
| Feature | Word |
| Attorney | See claim section below |
Yes. ONBEVC is currently a registered UK trademark, with renewal due on 2029-07-16. It is protected under UK intellectual property law and can be enforced against infringing uses.
The specification below is taken directly from the filed record at the UK IPO for each Nice class this trademark is registered in.
Pharmaceutical preparations; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treatment of diseases of the metabolic system; Pharmaceutical preparations for the treatment of inflammatory disorders; Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for skin care; Ophthalmic preparations; Ocular pharmaceuticals.
'ONBEVC' is a registered trademark on the UK IPO register, owned by Samsung Bioepis Co., Ltd.. The application (UK00918095804) was filed on 16 July 2019 and registered on 26 October 2019. The registration is set to expire on 16 July 2029.
This mark is recorded under Class 5 (pharmaceuticals & medical preparations).
The trademark is represented by BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB.
UK trademark UK00918095804 for the mark 'ONBEVC' in Class 5 is recorded on the UK IPO register as owned by Samsung Bioepis Co., Ltd.. This covers one specific UK trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Yes — the UK IPO records UK trademark UK00918095804 for the mark 'ONBEVC' as registered.
UK trademark UK00918095804 for the mark 'ONBEVC' is registered in Class 5 (pharmaceuticals & medical preparations). The filed specification reads: Class 5: Pharmaceutical preparations; Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for regulating the immune system; Pharmaceutical preparations for the treatment of autoimmune diseases; Pharmaceutical preparations for the treat…
UK trademark UK00918095804 for the mark 'ONBEVC' was filed at the UK IPO on 16 July 2019 and registered on 26 October 2019.
UK trademark UK00918095804 for the mark 'ONBEVC' is currently recorded as valid until 16 July 2029, at which point it will need to be renewed with the UK IPO to remain in force.
BOEHMERT & BOEHMERT Anwaltspartnerschaft mbB is listed as the attorney / representative of record for UK trademark UK00918095804 for the mark 'ONBEVC' on the UK IPO register.
This trademark has an attorney of record listed on the UK register. The firm has not yet claimed its listing on Trademark Dashboard.
Trademarks matching "ONBEVC" have been found on the following foreign registers. Exact matches appear first; where the name also appears inside longer filings, those are listed below as similar marks. A “Same applicant” badge appears next to a mark when the applicant name aligns with the source filing.
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ONBEVCSame applicant | 88519110 | 700 | 2019-07-17 |
Similar names
| Mark | Ref | Status | Filed |
|---|---|---|---|
| ONBEVCISame applicant | 88519118 | 700 | 2019-07-17 |
UK trademark data is supplied by the Intellectual Property Office under the Open Government Licence v3.0.
US trademark data is supplied by the United States Patent and Trademark Office. Works of the US federal government are in the public domain under 17 U.S.C. §105.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.